Want to show you something interesting
Now, most of my type 2 diabetes patients are on Acarbose.
Recently a patient was mine was not placed on Acarbose. He was on basal insulin with other OADs. I want to show you his AGP...
Now, most of my type 2 diabetes patients are on Acarbose.
Recently a patient was mine was not placed on Acarbose. He was on basal insulin with other OADs. I want to show you his AGP...
His AGP is very interesting. Look at the post meal excursions on a patient not on Acarbose.
Eventhough his Time in Range is good, high glycemic variablity is pretty high
Eventhough his Time in Range is good, high glycemic variablity is pretty high
This is his data from @Tidepool_org
His Time in range is 68% which is not too bad, but his SD is 45 mg/dl (I would like that in the 30's in a patient with mean glucose of 110 mg/dl) and his Coefficient of variation is 41% (should be less than 33%)
His Time in range is 68% which is not too bad, but his SD is 45 mg/dl (I would like that in the 30's in a patient with mean glucose of 110 mg/dl) and his Coefficient of variation is 41% (should be less than 33%)
The same day another patient showed up. Similar profile. He was also put on Basal insulin + OAD, but in his case we used Acarbose.
Look at his AGP data. Very little intraday variablity. So simply dont see those post meal peaks
Look at his AGP data. Very little intraday variablity. So simply dont see those post meal peaks
Now look at the @Tidepool_org data of Patient 2
Similar Average glucose value and GMI, but higher time in range and lower glycemic variablity
Similar Average glucose value and GMI, but higher time in range and lower glycemic variablity
Despite the minor problems like flatulence etc, I just thing Acarbose works. It just work so well in Indian type 2 diabetes patient.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
